Shenyang Xingqi Pharmaceutical Co.,Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 286.56 million compared to CNY 301.96 million a year ago. Revenue was CNY 286.56 million compared to CNY 301.96 million a year ago.

Net income was CNY 19.35 million compared to CNY 74.17 million a year ago. Basic earnings per share from continuing operations was CNY 0.1571 compared to CNY 0.6 a year ago. Diluted earnings per share from continuing operations was CNY 0.1571 compared to CNY 0.6 a year ago.